LpMab-23-recognizing cancer-type podoplanin is a novel predictor for a poor prognosis of early stage tongue cancer.
Oncotarget
; 9(30): 21156-21165, 2018 Apr 20.
Article
in En
| MEDLINE
| ID: mdl-29765527
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Oncotarget
Year:
2018
Document type:
Article
Affiliation country:
Japan